Melodi Health Announces $10.75 Million in Series A Funding, First Enrollment in Pivotal Clinical Trial Katie Lew · August 29, 2024
August 29, 2024 Melodi Health Announces $10.75 Million in Series A Funding, First Enrollment in Pivotal Clinical TrialGround-breaking investigational product from Melodi Health is designed to reduce post-surgical infections
August 27, 2024 NeuraWorx Partners with Corundum Neuroscience to Initiate Clinical Feasibility Study, Develop Innovative Neurological Disease TreatmentEXCELSIOR, Minn. – Aug. 27, 2024 – PRLog — NeuraWorx Medical Technologies, Inc., a neurotechnology therapeutics company, announced
August 27, 2024 Biocoat Incorporated Secures New Patent for Non-PFAS Inner Diameter CoatingHorsham, PA, [August 27, 2024] – Biocoat Incorporated, a leader in the
News, UncategorizedSPR® Therapeutics Announces Publication of Study Providing Evidence of the Impact of SPRINT® PNS Treatment in Relieving Postoperative Knee Pain Tyler MasonMay 15, 2024 SPR® Therapeutics Announces Publication of Study Providing Evidence of the Impact of SPRINT® PNS Treatment in Relieving Postoperative Knee Pain
NewsMedical Alley Announces Venture Capital Partnership with Capita3 Tyler MasonMay 15, 2024 Medical Alley Announces Venture Capital Partnership with Capita3
NewsMeet CareSpeak, your AI-Powered Telehealth Assistant Tyler MasonMay 14, 2024 Meet CareSpeak, your AI-Powered Telehealth Assistant
NewsChildren’s Minnesota Sleep Center Receives Re-Accreditation from the American Academy of Sleep Medicine Tyler MasonMay 14, 2024 Children’s Minnesota Sleep Center Receives Re-Accreditation from the American Academy of Sleep Medicine